BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 349924)

  • 1. [Renin-angiotensin and vasopressin in the pathogenesis of malignant hypertension].
    Möhring J
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():157-66. PubMed ID: 349924
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renin-angiotensin system in hypertension].
    Fyhrquist F
    Duodecim; 1974; 90(9):666-75. PubMed ID: 4371118
    [No Abstract]   [Full Text] [Related]  

  • 3. Saralasin in human hypertension: the early experience.
    Brunner HR; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renin-angiotensin system and hypertension. Morphology and function of the secretorily insufficient juxtaglomerular apparatus].
    Helmchen U; Dienemann H; Kneissler U; Stahl R; Kirchertz EJ
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():138-44. PubMed ID: 613559
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renin and sodium and the formation of vascular lesions in hypertension].
    Gavras H; Brunner HR
    Schweiz Med Wochenschr; 1974 Sep; 104(38):1301-10. PubMed ID: 4371116
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intrarenal regulation of sodium excretion in hypertension].
    Stumpe KO
    Ann Univ Sarav Med; 1974; 21(4):200-56. PubMed ID: 4369597
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of renin activity and aldosteronuria in 24 hypertensives].
    Sassard J; Bizollon A; Froment A; Vincent M; Lambrinidis S; Gharib C
    Rev Lyon Med; 1968 Oct; 17(16):697-706. PubMed ID: 4305353
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-angiotensin system and blood volume in patients with dialysis-resistant hypertension.
    Huysmans FT; Thien T; Koene RA
    Neth J Med; 1980; 23(2):74-8. PubMed ID: 6990283
    [No Abstract]   [Full Text] [Related]  

  • 10. Release of renin by human kidney slices, in vitro effect of angiotensin II, norepinephrine and aldosterone.
    Rosset E; Veyrat R
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):792-4. PubMed ID: 4331508
    [No Abstract]   [Full Text] [Related]  

  • 11. [SAR1, ALA8]-Angiotensin II (saralasin): a symposium. Introduction.
    Vaughan ED; Peach MJ
    Kidney Int Suppl; 1979 Mar; (9):S1-2. PubMed ID: 289858
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The kidney as an endocrine organ. I. Clinical significance of plasma renin determinations].
    Schalekampen MA; Birkenhäger WH
    Ned Tijdschr Geneeskd; 1974 Sep; 118(39):1479-85. PubMed ID: 4369695
    [No Abstract]   [Full Text] [Related]  

  • 14. [What role does the renin-angiotensin system have in the pathogenesis of hypertension?].
    Gross F; Dietz R; Lüth JB; Mann JF
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():177-87. PubMed ID: 613563
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the juxtaglomerular apparatus in experimental renovascular hypertension. I].
    Motolese Lazzàro O; Descovich GC; Descovich P
    Acta Chir Ital; 1966; 22 Suppl 1():137-54. PubMed ID: 4294850
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of renal hypertension].
    Cottier P
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1670-7. PubMed ID: 1215954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The surgical treatment of a patient with renovascular hypertension and the significance of the renin-angiotensin system in its development].
    Petrovskiĭ V; Krylov VS; Arabidze GG; Serebrovskaia IuA; Vikhert AM; Kramer AA
    Klin Med (Mosk); 1966 Oct; 44(10):19-27. PubMed ID: 4299896
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathophysiology of the renin-angiotensin system].
    Klett C; Hellmann W; Hackenthal E; Ganten D
    Wien Med Wochenschr; 1990 Jan; 140(1-2):2-12. PubMed ID: 2106755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.